
Forbes (blog)
<img alt="" height="1" width="1" />
Pfizer's Kidney Drug Also Slows Pancreatic Cancer
Forbes
Pfizer Inc., the world's biggest drugmaker, said Friday a late-stage trial of Sutent reveals that the kidney cancer treatment also helps slow the growth of rare pancreatic neuroendocrine tumors. Final results from a randomized Phase 3 trial of Sutent, ...
Pfizer: Kidney Drug Sutent Holds Off Pancreatic Cancer SpreadWall Street Journal
Pfizer: Sutent effective against pancreatic cancerMarketWatch
Data Show Progression-Free Survival Advantage With Sutent® In Patients With ...Business Wire (press release)
all 27 news articles »
More...